CAS 1001913-13-8

Formula: C25H30NNaO4S

InChI: InChI=1S/C25H31NO4S.Na/c1-16-7-9-18(10-8-16)24(28)26(19-11-13-20(27)14-12-19)21-15-22(31-23(21)25(29)30)17-5-3-2-4-6-17;/h2-6,15-16,18-20,27H,7-14H2,1H3,(H,29,30);/q;+1/p-1

InChI key: SSERCMQZZYTNBY-UHFFFAOYSA-M

SMILES: CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C4=CC=CC=C4)C(=O)[O-].[Na+]

VCH-759

CAS: 1001913-13-8

VCH-759 is a nucleoside analog that is a potential treatment for chronic hepatitis C. VCH-759 inhibits the NS5B polymerase of the hepatitis C virus, an enzyme responsible for viral replication. It binds to the active site of NS5B and prevents it from functioning. VCH-759 has shown antiviral effects in cell culture and animal models and has a safety profile comparable to other nucleoside analogs. The drug also appears to be effective against other types of viruses, including HIV, influenza A, and herpes simplex virus type 2. VCH-759 may be used as a single agent or in combination with other antivirals to treat patients with chronic viral infections.

Formula: C₂₅H₃₀NNaO₄S

Purity: Min. 95%

Molecular weight: 463.6 g/mol

Ref: 3D-BQB91313